Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma
Najam A. Sharif, Noriko Odani‐Kawabata, Fenghe Lu, et al.
Experimental Eye Research (2023) Vol. 229, pp. 109415-109415
Closed Access | Times Cited: 20

Showing 20 citing articles:

Human experience and efficacy of omidenepag isopropyl (Eybelis®; Omlonti®): Discovery to approval of the novel non-prostaglandin EP2-receptor-selective agonist ocular hypotensive drug
Najam A. Sharif
Current Opinion in Pharmacology (2024) Vol. 74, pp. 102426-102426
Closed Access | Times Cited: 4
Strategic approaches for antiglaucoma drug discovery—Successes and some failures
Najam A. Sharif
Elsevier eBooks (2025), pp. 359-383
Closed Access
Safety and efficacy of travoprost intracameral implant administered in combination with cataract surgery
Inder Paul Singh, Lilit Voskanyan, Kevin M. Barber, et al.
Therapeutic Advances in Ophthalmology (2025) Vol. 17
Open Access
Investigational drugs for glaucoma: novel mechanistic approaches of preclinical agents
Murat İrkeç, Anastasios G. Konstas, Gábor Holló, et al.
Expert Opinion on Investigational Drugs (2025)
Closed Access
Targeting EP2 Receptor for Drug Discovery: Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis
Thota Ganesh
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9313-9324
Open Access | Times Cited: 9
Identifying new drugs and targets to treat rapidly elevated intraocular pressure for angle closure and secondary glaucomas to curb visual impairment and prevent blindness
Najam A. Sharif
Experimental Eye Research (2023) Vol. 232, pp. 109444-109444
Closed Access | Times Cited: 8
Steroid-Induced Ocular Hypertension in Mice Is Differentially Reduced by Selective EP2, EP3, EP4, and IP Prostanoid Receptor Agonists
Najam A. Sharif, J. Cameron Millar, Gulab Zode, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3328-3328
Open Access | Times Cited: 2
New concept of etiopathogenesis and treatment of primary open-angle glaucoma
Rudkovska Oksana Dmytrivna
Advances in Ophthalmology & Visual System (2024) Vol. 14, Iss. 1, pp. 1-3
Open Access | Times Cited: 2
Recently Approved Drugs for Lowering and Controlling Intraocular Pressure to Reduce Vision Loss in Ocular Hypertensive and Glaucoma Patients
Najam A. Sharif
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 791-791
Open Access | Times Cited: 5
Tafluprost promotes axon regeneration after optic nerve crush via Zn2+-mTOR pathway
Siting Wu, Canying Liu, Jiahui Tang, et al.
Neuropharmacology (2023) Vol. 242, pp. 109746-109746
Closed Access | Times Cited: 5
The use of vitamin E in ocular health: Bridging omics approaches with Tocopherol and Tocotrienol in the management of glaucoma
Fazira Latib, Muhamad Arif Irfan Zafendi, Mohd Aizuddin Mohd Lazaldin
Food Chemistry Molecular Sciences (2024) Vol. 9, pp. 100224-100224
Open Access | Times Cited: 1
Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Shi‐Nan Wu, Caihong Huang, Yuqian Wang, et al.
Therapeutic Advances in Drug Safety (2024) Vol. 15
Open Access | Times Cited: 1
The Development of a SIBS Shunt to Treat Glaucoma
Leonard Pinchuk
Journal of Ocular Pharmacology and Therapeutics (2023) Vol. 39, Iss. 8, pp. 530-540
Closed Access | Times Cited: 2
A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of Latanoprost for Eyelash Growth in Aesthetic Medicine
Janette Ivone Espinoza-Silva, Ernesto Macias-Nevarez, Christian Q. Scheckhuber, et al.
Cosmetics (2023) Vol. 10, Iss. 5, pp. 136-136
Open Access | Times Cited: 2
Gene therapies and gene product-based drug candidates for normalizing and preserving tissue functions in animal models of ocular hypertension and glaucoma
Najam A. Sharif
Molecular Aspects of Medicine (2023) Vol. 94, pp. 101218-101218
Closed Access | Times Cited: 2

Rudkovska Oksana Dmytrivna
Advances in Ophthalmology & Visual System (2024) Vol. 14, Iss. 1
Open Access
Currently available prostanoids for the treatment of glaucoma and ocular hypertension: A review
Betsy Benitez, Abdelrahman M. Anter, Jennifer Arcuri, et al.
Current Opinion in Pharmacology (2023) Vol. 74, pp. 102424-102424
Closed Access | Times Cited: 1
Prostaglandin FP receptor agonists in the treatment of glaucoma and ocular hypertension: a literature review
Sophia Moshegov, Nathan M. Kerr
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 11, pp. 1017-1023
Closed Access
Comparative evaluation of the effectiveness of a prostaglandin analogue and fixed-dose combination drug containing brinzolamide 1% and timolol maleate 0.5% (an experimental study)
G. Ch. Javadova
National Journal glaucoma (2023) Vol. 22, Iss. 4, pp. 45-50
Open Access
Comparing IOP Measurements in the Iraqi Population: Goldmann Applanation Tonometer vs. Topcon CT-80 Air Puff Tonometer
Muna M. Kareem, Ahmed Mustafa Kareem
(2023) Vol. 24, pp. 177-180
Closed Access
Page 1

Scroll to top